IPP Bureau
Aster Health Academy announces strategic partnerships with premier Hospitals across India
By IPP Bureau - July 08, 2024
The academy has secured partnerships with 15 esteemed hospitals
Viatris closes divestitures of OTC business
By IPP Bureau - July 08, 2024
Achievement of This Major Milestone Further Simplifies and Strengthens the Company and Positions Viatris to Achieve its Key Priorities and Accelerate Future Growth
Shilpa's CDMO customer placed binding purchase order
By IPP Bureau - July 06, 2024
Nephro Care India lists at 90% premium
By IPP Bureau - July 06, 2024
NCIL was listed at Rs. 171 at an upper circuit premium of 90% over the fixed price band of Rs. 90
Dabur India updates on Q1 FY25
By IPP Bureau - July 06, 2024
Dabur's consolidated revenue is expected to register mid to high single digit growth during Q1 FY25
Biogen completes acquisition of HI-Bio
By IPP Bureau - July 06, 2024
Felzartamab demonstrated positive interim results from the Phase 2 IgA nephropathy (IgAN) study
FDA approves Roche’s Vabysmo PFS for three leading causes of vision loss
By IPP Bureau - July 06, 2024
Vabysmo PFS is the first and only syringe prefilled with an FDA-approved bispecific antibody to treat retinal conditions that can cause blindness
Merck inks MoU with Afrigen Biologics for development of mRNA vaccine technology platform
By IPP Bureau - July 05, 2024
Aim of the collaboration is to develop mRNA platform technology, scale up and troubleshoot challenges in mRNA process optimization
GSK and CureVac restructure collaboration into new licensing agreement
By IPP Bureau - July 05, 2024
CureVac receives €400 million upfront and up to an additional €1.05 billion in development, regulatory and sales milestone payments as well as tiered royalties; all previous financial considerations from the prior collaboration agreement replaced
Cardiological Society of India releases first Indian guidelines for dyslipidemia management
By IPP Bureau - July 05, 2024
Dyslipidemia is a critical risk factor for cardiovascular diseases
Briefs: Alembic Pharmaceuticals and Relonchem
By IPP Bureau - July 05, 2024
Alembic Pharmaceuticals receives 11 USFDA product approval during Q1 FY2025
Evonik appoints Yann d’Herve as new head of Health Care business line
By IPP Bureau - July 04, 2024
Yann d’Hervé takes over responsibility for the Health Care business at Evonik, effective July 1
Health Ministry issues advisory to states in view of zika virus cases from Maharashtra
By IPP Bureau - July 04, 2024
States urged to maintain a state of constant vigil through screening of pregnant women for Zika virus infection and monitoring the growth of foetus of expecting mothers who tested positive for Zika
Dr. B.N. Gangadhar appointed as Chairperson of the National Medical Commission
By IPP Bureau - July 04, 2024
Dr. Sanjay Behari, Director of Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, as the President of the Medical Assessment and Rating Board
Cupid Partners with SAP to Implement Advanced ERP System, SAP S/4HANA Cloud
By IPP Bureau - July 03, 2024
The integration of SAP S/4HANA Cloud will equip Cupid Limited with a comprehensive suite of integrated applications,
